Child pages
  • Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer (ARAR0331)

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 3 Next »

Summary

This collection contains data from the Children’s Oncology Group (COG) NCT00274937 ,"Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer". Principle Investigator: Carlos Rodriguez-Galindo,MD (Childrens Oncology Group).  It was sponsored by NCI and performed by the Children's Oncology Group under study number ARAR0331.   This phase III trial is studying how well radiation therapy, amifostine, and chemotherapy work in treating young patients with newly diagnosed nasopharyngeal cancer. Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs, such as amifostine, may protect normal cells from the side effects of radiation therapy. Drugs used in chemotherapy, such as cisplatin and fluorouracil, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving radiation therapy together with amifostine and chemotherapy may kill more tumor cells.



Data Access

Note to curators! This macro is for collections that are restricted due to facial reconstruction possibility.

Some data in this collection contains images that could potentially be used to reconstruct a human face. To safeguard the privacy of participants, users must sign and submit a TCIA Restricted License Agreement to help@cancerimagingarchive.net before accessing the data.

Note to curators! This macro is for collections that are restricted because of a PI's embargo request

Per the submitter's request, users must sign and submit a TCIA Restricted License Agreement to help@cancerimagingarchive.net before accessing certain data from this collection.

Note to curators! Only use the appropriate macro for your collection above, or the text below in the case of NCTN trials.  It will need to be tailored with the correct NCT#.

This is a limited access data set. To request access please register an account on the NCTN Data Archive.  After logging in, use the "Request Data" link in the left side menu.  Follow the on screen instructions, and enter  NCT00274937 when asked which trial you want to request.  In step 2 of the Create Request form, be sure to select “Imaging Data Requested”. Please contact NCINCTNDataArchive@mail.nih.gov for any questions about access requests.

Click the Versions tab for more info about data releases.

Note to curators! Use this any time you are linking to NCI's IDC/GDC/PDC resources.  The links below are examples and will need to be tailored to point to the specific dataset (see parameters in URLS).

Additional Resources for this Dataset

The NCI Cancer Research Data Commons (CRDC) provides access to additional data and a cloud-based data science infrastructure that connects data sets with analytics tools to allow users to share, integrate, analyze, and visualize cancer research data.


Note to curators! The link below is an example for NCTN trials and will need to be tailored to the proper URL for the corresponding data on the NCTN Data Archive.

Additional Resources for this Dataset

The National Cancer Institute (NCI) has created a centralized, controlled-access database, called the NCTN/NCORP Data Archive, for storing and sharing datasets generated from clinical trials of the National Clinical Trials Network (NCTN) and the NCI Community Oncology Research Program (NCORP). Clinical data from the participants in this trial can be found at:


Note to curators! Below are examples for what to do with other external resources/links that don't fit into the above categories.

Additional Resources for this Dataset

The following external resources have been made available by the data submitters.  These are not hosted or supported by TCIA, but may be useful to researchers utilizing this collection.

  • Software / Code on Github
  • Genomics data in DbGAP
  • Genomics data in Gene Expression Omnibus


Detailed Description

Image Statistics

Radiology Image StatisticsPathology Image Statistics

Modalities



Number of Patients

108


Number of Studies



Number of Series



Number of Images



Images Size (GB)

<< Add any additional information that didn't fit or belong in the Summary section. >>

De-identification of DICOM dates

De-identification of dates for this dataset uses the DICOM Part 3.15 Annex E standard “Retain Longitudinal With Modified Dates Option” which allows dates to be retained as long as they are modified from the original date.  TCIA implements this using a technique which de-identifies the dates while preserving the longitudinal relationship between them.  Original dates will be first normalized to 01 January, 1960 and then offset relative to the date of registration for each patient.  This normalized date system was chosen in order to make it obvious that the dates are not real, and to make it easy to quickly determine how much time has passed between the date of registration and the patients' related imaging studies. 

For example, if the real date of a patient's registration was 03/27/2018 and the original imaging Study Date was 03/29/2018 then the "Days from registration" would be +2 and the anonymized TCIA Study Date would become 01/03/1960.

Insertion of computed "REGISTRATION"/Days offset from registration" value

In addition to modifying the actual date fields in the DICOM header, the "days from registration" values are calculated and stored in the DICOM tag (0012,0052) Longitudinal Temporal Offset from Event with the associated tag (0012,0053) Longitudinal Temporal Event Type set to “REGISTRATION”. 

Note: If these DICOM tags are not present, DICOM tag (0012,0050) Clinical Trial Time Point ID with the associated tag (0012,0051) Clinical Trial Time Point Description provides this same information.  This inconsistency is due to a change in how dates were handled in the first NCTN trials that were published on TCIA.


Citations & Data Usage Policy

Users must abide by the TCIA Data Usage Policy and Restrictions. Attribution should include references to the following citations:

Data Citation

DOI goes here. Create using Datacite with information from Collection Approval form

Publication Citation

We ask on the proposal form if they have ONE traditional publication they'd like users to cite.

Acknowledgement

Required acknowledgements only (ex:The CPTAC program requests that publications using data from this program...). If they just want to thank someone, that goes in the Acknowledgement section underneath the Summary.

TCIA Citation

Clark K, Vendt B, Smith K, Freymann J, Kirby J, Koppel P, Moore S, Phillips S, Maffitt D, Pringle M, Tarbox L, Prior F. The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository, Journal of Digital Imaging, Volume 26, Number 6, December, 2013, pp 1045-1057. DOI: 10.1007/s10278-013-9622-7

Other Publications Using This Data

TCIA maintains a list of publications which leverage TCIA data. If you have a manuscript you'd like to add please contact the TCIA Helpdesk.

Version X (Current): Updated yyyy/mm/dd

<< One or two sentences about what you changed since last version.  No note required for version 1. >> 



  • No labels